13 cases of early senile guilain-barre syndrome treatment effect is observed
Objective: To observe the immune globulin for early clinical therapeutic effects of senile guilain-barre syndrome, to find a more suitable way of clinical treatment. Methods: 26 cases of senile patients with guilain-barre syndrome were randomly divided into obser-vation group and control group, each group of 13 cases of observation group was treated with high-dose immunoglobulin, the control group given dexamethasone impact treatment, at the same time two groups of patients were given vitamin B group, improve blood circulation, nutrition and suit the support base treatment. Treatment in 20 days observing two groups of patients with muscle recovery. Results: the observation group of patients with clinical efficient (84.6%) is significantly higher than the control group (53.8%), with statistical significance (P< 0.05). Conclusion: the treatment of early senile guilain-barre syndrome clinical curative effect was better than hormone shock therapy, and less adverse reaction, high security, is the preferred treatment for the treatment of the disease.